KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Insulet (PODD) over the last 17 years, with Q3 2025 value amounting to $25.6 million.

  • Insulet's Capital Expenditures fell 411.99% to $25.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.1 million, marking a year-over-year increase of 944.33%. This contributed to the annual value of $124.9 million for FY2024, which is 6521.16% up from last year.
  • Latest data reveals that Insulet reported Capital Expenditures of $25.6 million as of Q3 2025, which was down 411.99% from $18.6 million recorded in Q2 2025.
  • Insulet's Capital Expenditures' 5-year high stood at $64.4 million during Q4 2022, with a 5-year trough of $10.5 million in Q1 2023.
  • In the last 5 years, Insulet's Capital Expenditures had a median value of $22.5 million in 2024 and averaged $25.9 million.
  • Per our database at Business Quant, Insulet's Capital Expenditures plummeted by 6109.42% in 2022 and then surged by 11047.62% in 2024.
  • Quarter analysis of 5 years shows Insulet's Capital Expenditures stood at $31.8 million in 2021, then soared by 102.52% to $64.4 million in 2022, then plummeted by 54.5% to $29.3 million in 2023, then skyrocketed by 82.94% to $53.6 million in 2024, then plummeted by 52.24% to $25.6 million in 2025.
  • Its Capital Expenditures stands at $25.6 million for Q3 2025, versus $18.6 million for Q2 2025 and $12.3 million for Q1 2025.